{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T06:09:57Z","timestamp":1648879797160},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Huazhong Univ. Sc. Technol."],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1007\/s11596-007-0208-9","type":"journal-article","created":{"date-parts":[[2007,5,13]],"date-time":"2007-05-13T12:55:40Z","timestamp":1179060940000},"page":"142-144","source":"Crossref","is-referenced-by-count":3,"title":["Evaluation on the safety and efficacy of tirofiban in the treatment of acute coronary syndrome"],"prefix":"10.1007","volume":"27","author":[{"given":"Yu\u2019e","family":"Song","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"20","key":"208_CR1","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1161\/01.CIR.0000017635.82128.8C","volume":"105","author":"G. W. Stone","year":"2002","unstructured":"Stone G W, Moliterno D J, Bertrand M et al. Impact of clinical syndrome acuity on the differential response to 2 glycoprotein llb\/llla inhibitors in patients undergoing coronary stenting: The TARGET Trial. Circulation, 2002;105(20):2347\u20132354","journal-title":"Circulation"},{"key":"208_CR2","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1345\/aph.1C338","volume":"37","author":"M. A. Crouch","year":"2003","unstructured":"Crouch M A, Nappi J M, Cheang K I. Glycoprotein llb\/llla receptor inhibitors in percutaneous coronary intervention and acute coronary syndrome. Ann Pharmacother, 2003,37:860\u2013875","journal-title":"Ann Pharmacother"},{"issue":"2","key":"208_CR3","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1253\/circj.69.159","volume":"69","author":"J. H. Kim","year":"2005","unstructured":"Kim J H, Jeong M H, Rhew J Y et al. Long-term clinical outcomes of platelet glycoprotein llb\/llla inhibitor combined with low molecular weight heparin in patients with acute coronary syndrome. Circ J, 2005,69(2):159\u2013164","journal-title":"Circ J"},{"issue":"5","key":"208_CR4","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1161\/01.CIR.96.5.1445","volume":"96","author":"The RESTORE investigators.","year":"1997","unstructured":"The RESTORE investigators. Effects of platelet glycoprotein llb\/llla blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. Circulation, 1997;96(5):1445\u20131453","journal-title":"Circulation"},{"issue":"21","key":"208_CR5","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1056\/NEJM199805213382102","volume":"338","author":"The PRISM-PLUS Study Investigators.","year":"1998","unstructured":"The PRISM-PLUS Study Investigators. Inhibition of the platelet glycoprotein llb\/llla receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. N Engl J Med, 1998, 338(21):1488\u20131497","journal-title":"N Engl J Med"},{"issue":"19","key":"208_CR6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0140-6736(02)07442-1","volume":"359","author":"E. Boersma","year":"2002","unstructured":"Boersma E, Harrington R A, Moliterno D J et al. Platelet glycoprotein llb\/llla inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials. Lancet, 2002, 359(19):189\u2013198","journal-title":"Lancet"},{"issue":"4","key":"208_CR7","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1161\/01.CIR.90.4.1757","volume":"90","author":"J. E. Tcheng","year":"1994","unstructured":"Tcheng J E, Ellis S E, George B S et al. Pharmacodynam-ics of chimeric glycoprotein llb\/llla integrin antiplatelet anti-body Fab 7E3 in high-risk coronary angioplasty. Circulation, 1994;90(4):1757\u20131764","journal-title":"Circulation"}],"container-title":["Journal of Huazhong University of Science and Technology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-007-0208-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11596-007-0208-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-007-0208-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T13:14:53Z","timestamp":1559394893000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11596-007-0208-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":7,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["208"],"URL":"https:\/\/doi.org\/10.1007\/s11596-007-0208-9","relation":{},"ISSN":["1672-0733","1993-1352"],"issn-type":[{"value":"1672-0733","type":"print"},{"value":"1993-1352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}